Skip to Main Content

Author Details

Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
2015
27
17
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37550340A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach.Sci Rep2023
37758692Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.Nat Commun2023
35027731BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.Nat Cell Biol2022
35360100Exploring Zebrafish Larvae as a COVID-19 Model: Probable Abortive SARS-CoV-2 Replication in the Swim Bladder.Front Cell Infect Microbiol2022
34326236Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.Science2021
33791693Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2.bioRxiv2021
33864728Host PDZ-containing proteins targeted by SARS-CoV-2.FEBS J2021
33863888Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts.Nat Commun2021
33556143Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.PLoS Pathog2021
33501440BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.bioRxiv2021
34499915Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells.J Theor Biol2021
34468175Intra- and Inter-cellular Modeling of Dynamic Interaction between Zika Virus and Its Naturally Occurring Defective Viral Genomes.J Virol2021
32429277Modelling Degradation and Replication Kinetics of the Zika Virus In Vitro Infection.Viruses2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33154106An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.Science2020
32817938An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation.bioRxiv2020
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
32353859A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.Nature2020
30567991M Segment-Based Minigenomes and Virus-Like Particle Assays as an Approach To Assess the Potential of Tick-Borne <i>Phlebovirus</i> Genome Reassortment.J Virol2019
31710653Host nutritional status affects alphavirus virulence, transmission, and evolution.PLoS Pathog2019
31270226Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated <i>In Vivo</i> and Have Compromised Transmissibility.J Virol2019
29695422Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20.J Virol2018
30099321The defective component of viral populations.Curr Opin Virol2018
28680969Differential Antagonism of Human Innate Immune Responses by Tick-Borne <i>Phlebovirus</i> Nonstructural Proteins.mSphere2017
28592543Mapping of Transcription Termination within the S Segment of SFTS Phlebovirus Facilitated Generation of NSs Deletant Viruses.J Virol2017
27706161Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil.PLoS Negl Trop Dis2016
25673721Generation of mutant Uukuniemi viruses lacking the nonstructural protein NSs by reverse genetics indicates that NSs is a weak interferon antagonist.J Virol2015
  • 1 - 27 of 27

Recommended Authors

Horacio M Pallar??s
Fundacion Instituto Leloir-CONICET
Career Start Year 2017
Number of shared co-authors 1
Chengjin Ye
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 26
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 1
Chao Shan
Wuhan Institute of Virology, Chinese Academy of Sciences
Career Start Year 2012
Number of shared co-authors 2
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 21
Xuping Xie
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 6
Kenneth S Plante
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 0
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 14
Velmurugan Balaraman
College of Veterinary Medicine, Kansas State University
Career Start Year 2009
Number of shared co-authors 9
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 1
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 7
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 5
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 4
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 14
Shannan L Rossi
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 1
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 1
Rachel L Graham
University of North Carolina
Career Start Year 2004
Number of shared co-authors 0
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 5
Priya S Shah
University of California davis
Career Start Year 2002
Number of shared co-authors 15
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 38
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Career Start Year 2000
Number of shared co-authors 7
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 10
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 9
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 16
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 4
Sara Cherry
University of Pennsylvania
Career Start Year 1993
Number of shared co-authors 13
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 20
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 2
Michael S Diamond
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 17
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 7

Collaborators

Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 21
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 8
Thomas Vallet
Institut Pasteur, Center for the Viral Populations and Pathogenesis
Co-authored papers 8
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 8
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Kevan M Shokat
University of California San Francisco
Co-authored papers 6
Danielle L Swaney
J. David Gladstone Institutes
Co-authored papers 6
Brian K Shoichet
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 6
Tia A Tummino
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 5
Melanie Ott
Gladstone Institute of Virology
Co-authored papers 5
Robyn M Kaake
J. David Gladstone Institutes
Co-authored papers 4
Matthew J O'Meara
University of Michigan ann arbor
Co-authored papers 4
Mehdi Bouhaddou
J. David Gladstone Institutes
Co-authored papers 4
Margaret Soucheray
J. David Gladstone Institutes
Co-authored papers 4
Raphael Trenker
Cardiovascular Research Institute, University of California San Francisco
Co-authored papers 4
Jared Carlson-Stevermer
Synthego Corporation
Co-authored papers 4
Jyoti Batra
J. David Gladstone Institutes
Co-authored papers 4
Hannes Braberg
University of California San Francisco
Co-authored papers 3
Cristina Puchades
University of California San Francisco (UCSF) School of Medicine
Co-authored papers 3
Caleigh M Azumaya
Fred Hutchinson Cancer Center
Co-authored papers 3
Christian B Billesb??lle
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 3
Henry C Nguyen
Shanghai Clinical Research and Trial Center
Co-authored papers 3
Beril Tutuncuoglu
University of California san francisco
Co-authored papers 3
Ishan Deshpande
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 3
Ying Shi
Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences
Co-authored papers 3
Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 3
David E Gordon
Emory University
Co-authored papers 3
Gregory E Merz
University of California san francisco
Co-authored papers 3
Danish Memon
European Bioinformatics Institute
Co-authored papers 3
Aashish Manglik
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 3
Release 1.2